News Sentiment

600196 sentiment intelligence

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 20 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 23.40 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-0.2% over one week, +7.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Fosun Pharma stock holds firm as revenue grows and R&D spending rises

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -0.2% Price digesting
Trend fit Trend inactive 7.4% over four weeks
Fair value -7.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 18
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Fierce Pharma 4
Ad-hoc-news.de 3
South China Morning Post 3
富途牛牛 2
BioWorld News 2
BioSpace 1
Bloomberg.com 1
Reuters 1

Event Lens

What the news is about

Classified themes
Market update 13
Deals and strategy 3
Earnings 1
Capital return 1
Regulatory and legal 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20